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MaBACKGROUND Functional decline in stem cell–mediated regeneration contributes to aging associated with cellular
senescence in c-kitþ cardiac progenitor cells (CPCs). Clinical implementation of CPC-based therapy in elderly patients
would beneﬁt tremendously from understanding molecular characteristics of senescence to antagonize aging. Nucle-
ostemin (NS) is a nucleolar protein regulating stem cell proliferation and pluripotency.
OBJECTIVES This study sought to demonstrate that NS preserves characteristics associated with “stemness” in CPCs
and antagonizes myocardial senescence and aging.
METHODS CPCs isolated from human fetal (fetal human cardiac progenitor cell [FhCPC]) and adult failing (adult human
cardiac progenitor cell [AhCPC]) hearts, as well as young (young cardiac progenitor cell [YCPC]) and old mice (old cardiac
progenitor cell [OCPC]), were studied for senescence characteristics and NS expression. Heterozygous knockout mice
with 1 functional allele of NS (NSþ/-) were used to demonstrate that NS preserves myocardial structure and function and
slows characteristics of aging.
RESULTS NS expression is decreased in AhCPCs relative to FhCPCs, correlating with lowered proliferation
potential and shortened telomere length. AhCPC characteristics resemble those of OCPCs, which have a phenotype
induced by NS silencing, resulting in cell ﬂattening, senescence, multinucleated cells, decreased S-phase
progression, diminished expression of stemness markers, and up-regulation of p53 and p16. CPC senescence
resulting from NS loss is partially p53 dependent and is rescued by concurrent silencing of p53. Mechanistically,
NS induction correlates with Pim-1 kinase-mediated stabilization of c-Myc. Engineering OCPCs and AhCPCs to
overexpress NS decreases senescent and multinucleated cells, restores morphology, and antagonizes senescence,
thereby preserving phenotypic properties of “stemness.” Early cardiac aging with a decline in cardiac function, an
increase in senescence markers p53 and p16, telomere attrition, and accompanied CPC exhaustion is evident in
NSþ/- mice.
CONCLUSIONS Youthful properties and antagonism of senescence in CPCs and the myocardium are consistent with a
role for NS downstream from Pim-1 signaling that enhances cardiac regeneration. (J Am Coll Cardiol 2015;65:133–47)
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ABBR EV I A T I ON S
AND ACRONYMS
AhCPC = adult human cardiac
progenitor cell
BrdU = 5-bromo-2-
deoxyuridine
CPC = cardiac progenitor cell
FhCPC = fetal human cardiac
progenitor cell
GFP = green ﬂuorescent
protein
mRNA = messenger ribonucleic
acid
NS = nucleostemin
NSþ/- = nucleostemin
heterozygous knockout mice
OCPC = old cardiac progenitor
cell
SA-b-gal = senescence-
associated beta-galactosidase
YCPC = young cardiac
progenitor cell
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134C ardiac aging is a heterogeneous pro-cess accompanied by loss of tissuehomeostasis and decreased organ
function. Decline in stem cell function and
regenerative capacity is a leading factor
contributing to aging (1). The adult heart is
home to resident c-kitþ cardiac progenitor
cells (CPCs) that are clonogenic and self-
renewing, and can differentiate into cardio-
myogenic lineages (2), but aging alters CPC
properties, leading to progressive accumula-
tion of senescent stem cells with decreased
proliferative and regenerative potential (1).
Identifying “stem cell–associated molecules”
and their mechanism of regulation is essen-
tial to enhance the therapeutic potential of
stem cell–based repair. Because cardiac
stem cell therapy would be targeted to a pre-
dominantly geriatric population, deﬁning
molecular antagonism of senescence in a
stem cell context would be both clinically
relevant and highly signiﬁcant.SEE PAGE 148A stem cell–related nucleolar protein required for
cell cycle progression and proliferation (3,4), nucle-
ostemin (NS) delays senescence, with mouse embry-
onic ﬁbroblasts isolated from NS heterozygous
knockout mice (NSþ/-) exhibiting decreased prolif-
eration and increased senescent cells on passaging in
culture (5). NS is also associated with maintenance of
stem cell pluripotency, survival, and commitment
(4,6,7). Expression of NS decreases rapidly before
stem cell differentiation, and its loss increases dif-
ferentiation in multiple stem cells (4,7). Associated
with increased proliferation of cardiac myocytes and
CPCs, cardiac NS expression declines with aging (8).
NS also functions as a nucleolar stress sensor in
response to cardiac stress and regulates p53 (6), a cell
cycle inhibitor typically associated with increased
senescence (9). NS-mediated regulation of p53 is cell-
type speciﬁc (4,10,11), such that consequences of NS
action in selected cell-type populations remain
obscure. The role of NS in antagonizing senescence in
adult stem cells, including CPCs, remains speculative
and requires investigation.
NS expression in the heart coincides with Pim-1, a
serine threonine kinase that enhances regenera-
tive potential by exerting pro-survival and pro-
proliferative effects (8,12,13). Coincident functions
of Pim-1 and NS suggest that NS may be regulated by
Pim-1, which phosphorylates and stabilizes tran-
scription factor c-Myc and, via c-Myc, regulates mul-
tiple functions in cancer and stem cells, includingCPCs (14-17). Collectively, these observations prompt
the hypothesis that Pim-1 regulates NS via c-Myc in
CPCs. Delineating this molecular pathway on a
mechanistic level provides substantial insight into
the underlying basis for regulation of senescence and
suggests therapeutic intervention strategies that
might promote youthfulness in the CPC population.
This study delineates the role of NS in CPC “stem-
ness,” as deﬁned by morphological and functional
characteristics and expression of molecular markers,
and establishes a relationship to Pim-1 by: 1) deter-
mining phenotypic characteristics of senescent CPCs;
2) establishing NS antagonism of senescence in CPCs;
3) delineating upstream molecular signaling regu-
lating NS; 4) demonstrating NS overexpression as an
effective strategy to enhance “youthful” characteris-
tics of senescent CPCs; and 5) validating that NS is
required to maintain myocardial youth.
METHODS
Cell culturing involved c-kitþ CPCs isolated from 3-
and 13-month-old male FVB mice hearts, human
patients receiving a left ventricular assist device, and
spontaneously aborted human fetuses at 16 to 17
weeks of age. The cardiac region from nonfailing
human hearts included the mid left ventricle free wall
with full thickness from epicardium to endocardium.
Human fetal and adult failing myocardium were ob-
tained, as previously described (13). The adult and
fetal whole heart tissue was used either for isolation
of adult human cardiac progenitor cells (AhCPCs) or
fetal human CPCs (FhCPCs) or for biochemical ana-
lyses. Each sample was isolated from a different
patient; tissue from individual patients was not
combined. Experimental values obtained from mul-
tiple patients of a sample category (fetal, adult
failing, adult nonfailing) were averaged for statistical
analyses. The Online Appendix contains a more
extensive explanation of the methods.
RESULTS
CELLULAR SENESCENCE IN CPCS CORRELATES
WITH NS LOSS. AhCPCs were compared with
FhCPCs, which served as a reference for “youthful
phenotypic characteristics” (13). NS is signiﬁcantly
decreased in multiple AhCPC lines relative to FhCPCs
(55%) (Figure 1A), and NS loss correlates with
impaired proliferative potential of AhCPCs (Figure 1B)
consistent with prior reports assessing AhCPC growth
characteristics (13). NS expression strongly correlates
with telomere length (Figure 1C) as determined pre-
viously (13). The adult human heart under normal
conditions expresses relatively low levels of NS
FIGURE 1 NS Expression in Human CPCs and Myocardium
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(A) Immunoblot and densitometric analyses of NS expression in multiple adult human CPC (AhCPC) lines relative to fetal human CPC (FhCPC)
lines. Line numbers are indicated above the blot (N ¼ 3 FhCPC lines and 9 AhCPC lines). (B) NS expression in AhCPC lines classiﬁed as fast,
medium, or slow growers. (C) Pearson correlation coefﬁcient between NS expression and telomere length (Kbp) in hCPCs (r¼0.67). (B, C)N¼ 10
AhCPCs (salmon, dark gray, yellow bars/dots), mean of 3 FhCPCs (blue bar/dot). (D) Immunoblot and densitometric analyses show NS
expression in adult failing (left ventricular assist device [LVAD]) and nonfailing (ADNF) hearts relative to fetal hearts (FH) (N ¼ 3 fetal, 3 failing,
and 6 non-failing hearts). (E) Telomere length decreases with aging. N ¼ 4 fetal, 6 LVAD hearts. (F) Pearson correlation coefﬁcient between NS
expression and telomere length in human hearts is shown (r ¼ 0.86). hCPCs were at mid passages (p6-8). *p < 0.05; **p < 0.01; ***p < 0.001.
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136(Figure 1D), consistent with nominal cell growth and
proliferation under basal conditions. Corroborating
ﬁndings in CPC lines, speciﬁcally human myocardial
lysates of adult failing hearts, revealed signiﬁcant
reduction in NS expression (43%) (Figure 1D) and
telomere length (56%) (Figure 1E) relative to fetal
human hearts, reinforcing a signiﬁcant correla-
tion between NS expression and telomere length
(Figure 1F). Collectively, the results demonstrate
reduced NS levels associated with increased senes-
cence and aging.
Cellular senescence was evaluated in AhCPCs,
FhCPCs, and CPCs from old (13 months, OCPCs) and
young mice (3 months, YCPCs) to better deﬁne the
cell-speciﬁc role of NS in senescence, as evidenced by
phenotypic and molecular characteristics. Morpho-
logical changes associated with “cell ﬂattening,”
observed as increased cross-sectional area and
roundness and decreased length/width ratio, were
evident in OCPCs and AhCPCs relative to YCPCs and
FhCPCs (Figure 2A), consistent with previous ﬁndings
(13). Cell ﬂattening was also evident 3-dimensionally
as thinner cells (Online Figure 1). Senescent cell fre-
quency increased in OCPCs (15-fold) and AhCPCs
relative to YCPCs as revealed by senescence-
associated beta-galactosidase (SA-b-gal) (Figures 2A
and 2B). Decreased proliferation (75%) consistent
with increased G1 (28%) and diminished S (62%) and
G2 (59%) cell cycle phases was evident in OCPCs
(Online Figures 2A and 2B). Cellular senescence in
CPCs was also associated with multinucleation
(Figure 2C), predominantly by OCPCs and AhCPCs
becoming increasingly binucleated with polynucleate
cells (>2 nuclei) detected only in mouse OCPCs.
Furthermore, SA-b-galþ binucleate and polynucleate
cell number was increased in OCPCs (Online
Figure 2C), thereby linking cell-autonomous multi-
nucleation with senescence. Corroborating in vivo
ﬁndings with myocardial sections reveal senescent
CPCs, identiﬁable as large c-kitþ cells concurrently
labeled for g-H2AX, a deoxyribonucleic acid damage
response and senescence marker (18), were signiﬁ-
cantly more abundant (35%) in sections from
12-month-old versus 3-month-old mouse hearts
(Online Figures 2D and 2E). Binucleated CPCs were
increased by 3-fold in 12-month-old hearts and 67% of
binucleated CPCs were g-H2AXþ (Online Figures 2F
and 2G), reinforcing the relationship between binu-
cleation and senescence. Concurrence of lowered NS
expression in OCPCs with ﬂattened morphology and
senescence occurs in conjunction with binucleated
SA-b-galþ cells (Figure 2D, Online Figure 2H). Flat-
tened and binucleate AhCPCs consistently display
dramatically reduced NS levels relative to FhCPCs(Online Figure 2I), demonstrating a cell autonomous
role for decline in NS and cellular senescence.
Striking morphologic changes demonstrate the
functional impact of NS silencing in multiple AhCPC
and mouse CPC isolates (75%) prompting cell ﬂat-
tening and increases in senescent (37%) and binu-
cleated (48%) cells (Figures 2E to 2H). Similar ﬁndings
of ﬂattening, increased SA-b-gal activity (3.5-fold),
and multinucleation also were observed after NS
silencing in mouse CPCs (Online Figure 3), further
reinforcing a causal role for NS in regulating CPC
morphology and senescence.
PROLIFERATION AND MAINTENANCE OF “STEMNESS”
IN CPCS REQUIRES NS. Decline in proliferation (42%)
(Figure 3A) correlates with increased G1 (7%)
concomitant with decreases in S (69%) and G2
phases (47%) (Online Figure 4A) in YCPCs on NS
silencing. Reduction in S phase on NS knockdown was
conﬁrmed by 5-bromo-2-deoxyuridine (BrdU) incor-
poration (62%) (Figure 3B). Cell cycle stage relative
to NS-mediated regulation was revealed using
nuclear-localized ﬂuorescent ubiquitination-based
cell cycle indicator that shows G1 phase by expres-
sion of truncated Cdt1 fused to monomeric Kusabira
Orange, S to M phase by expression of truncated
geminin fused to Azami green, with G1-S phase tran-
sition expressing both and appearing yellow (19). NS
knockdown-induced senescence prompts cell cycle
arrest as evidenced by decreased S to M phase with
fewer Azami greenþ cells (42%) (Online Figure 4B)
together with G1 phase accumulation revealed by
monomeric Kusabira Orangeþ seen in SA-b-galþ
senescent cells (Figure 3C).
Cell cycle inhibitors associated with senescence (9)
were increased by NS silencing in YCPCs (Figure 3D)
and AhCPCs (Online Figure 4C) as exempliﬁed by
higher p53 (1.9-fold) and p16 (2-fold) expression
without affecting basal cell death (Online Figure 4D).
Decreases in cyclin D1 (41%) and Aurora B kinase
(60%) (Figure 3D) required for progression through G1
and cytokinesis, respectively, followed NS knockdown
(20). Reduction in c-kit protein (42%) and messenger
ribonucleic acid (mRNA) expression (46%) was
observed after NS knockdown (Figure 3D, Online
Figure 4E). Other markers of multipotency, such as
KLF4, Nanog, and Oct4, were also decreased on NS
knockdown, consistent with loss of stemness
(Figure 3E). Early mRNA markers for lineage com-
mitment, including cardiomyogenic genes SM-22,
a-smooth muscle actin, and myocyte enhancer-
binding factor-2c, were signiﬁcantly decreased on NS
silencing in YCPCs (Online Figure 4E). Commitment of
CPCs by dexamethasone, a nonspeciﬁc inducer of
FIGURE 2 NS Loss Causes Altered Morphology During Senescence
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(A) Phase-contrast microscopy of young CPCs (YCPCs) and old CPCs (OCPCs) from mice, and FhCPC and AhCPC (lines FH-05 and H10-004) stained with
senescence-associated beta-galactosidase (SA-b-gal). Arrows indicate blue, senescent cells. (B) Graph indicates senescent cell counts. (C) Phase-contrast images of
SA-b-galþ binucleate (2 nuclei, binuc.) and polynucleate (>2 nuclei, polynuc.) cells, and percentage of multinucleate YCPC/OCPCs are shown. (D) NS declines in
ﬂat, senescent OCPCs (arrows). Confocal microscopy of OCPCs stained with phalloidin (Phal, dark gray), NS (red), and SYTOX Blue (Life Technologies, Carlsbad,
California) (SB, blue) (left). Phase-contrast image of the same cells treated with SA-b-gal (right). (E) Immunoblot and densitometric analyses showing NS
knockdown in YCPCs (N ¼ 12). (F) Phase-contrast (top, line H10-005) and electron micrographs (bottom, line H11-020) of AhCPCs with NS knockdown
demonstrating ﬂattened SA-b-galþ cells (arrows). Senescent (G) and binucleated cell count (H) (N > 200 cells). Scale bar: 100 mm (A, C, F) and 50 mm (D).
*p < 0.05; **p < 0.01; ***p < 0.001 (relative to each corresponding group in YCPCs in C). Lt-sh ¼ lentivirus harboring short hairpin ribonucleic acid; other
abbreviations as in Figure 1.
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FIGURE 3 NS Silencing Causes Cell Cycle Arrest and Senescence in YCPCs
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(A) Proliferation rate determined by CyQUANT assay (Life Technologies) (N ¼ 5). (B) 5-bromo-2-deoxyuridine (BrdU) incorporation measured
by ﬂuorescence activated cell sorting (FACS) (N ¼ 3). (C) Images of YCPCs expressing ﬂuorescence ubiquitination cell cycle indicator constructs
stained with SA-b-gal. (D) Immunoblot and densitometric analyses of p53 (N ¼ 13), p16 (N ¼ 5), cyclin D1 (N ¼ 3), Aurora B (N ¼ 3), and c-kit
(N ¼ 6) in YCPCs. (E) Immunoblots of multipotency markers KLF4, Nanog, and Oct 4 in YCPCs. Positive (Pos.) control: mouse embryonic stem
cell lysate. (F) Immunoblot and densitometric analyses of a-smooth muscle actin (a-SMA) expression in YCPCs cultured in normal or alpha
minimum essential media (aMEM) with or without dexamethasone (Dex) (N ¼ 3). Scale bar: 100 mm. *p < 0.05; **p < 0.01. Abbreviations as in
Figures 1 and 2.
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138differentiation, was similarly blunted as determined
by lowered a-smooth muscle actin protein expression
(Figure 3F). Collectively, these results indicate that
the cell-cycle arrest resulting from NS knockdown
does not operate via initiation of enhanced lineage
commitment.
CPC SENESCENCE INDUCED BY NS KNOCKDOWN IS
PARTLY P53 DEPENDENT. Mechanistic involvement
of p53 in NS silencing-induced senescence wasdetermined by stably silencing p53 (46%) before NS
knockdown in YCPCs and AhCPCs (Figure 4A). p53
knockdown increased proliferation of YCPCs both at
baseline (25%) and after NS silencing (53.5%)
(Figure 4B). NS silencing-induced morphological ﬂat-
tening was inhibited by concurrent p53 knockdown in
AhCPCs, similar to ﬁndings in YCPCs (Figure 4C,
Online Figures 5A to 5C). Furthermore, loss of p53
signiﬁcantly attenuated NS knockdown-induced
FIGURE 4 NS Silencing–Mediated CPC Senescence Is Partly p53 Dependent
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139increase in SA-b-galþ cells (43%) (Figures 4C and
4D). However, NS silencing-induced multinucleation
is p53 independent, because concurrent loss of
p53 and NS does not decrease the percentage of
multinucleate cells (Figure 4E). Thus, functionaleffects of p53 knockdown on senescence characteris-
tics were primarily evident in the mononucleate
cell population, supporting the contention that
NS silencing-induced senescence is partially p53
dependent.
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140REGULATION OF NS EXPRESSION DEPENDS ON
PIM-1–MEDIATED STABILIZATION OF C-MYC. Estab-
lishing that NS inﬂuences CPC proliferation and
senescence (Figures 1 to 4) prompted examination of
the relationship between NS and Pim-1, since initial
NS studies showed correlation with Pim-1 in the
pathologically injured heart (8). Indeed, Pim-1 over-
expression in YCPCs (CPCeP) induces signiﬁcant in-
creases in c-Myc and NS expression (79% and 40%,FIGURE 5 Pim-1 Regulates c-Myc and NS
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141heart lysates reveal Pim-1–dependent regulation of
NS that tracks with c-Myc levels.
In relating murine ﬁndings to human CPCs, AhCPC
lines were genetically modiﬁed to overexpress Pim-1
and green ﬂuorescent protein (GFP) (hCPCeP) or ex-
press GFP alone (hCPCe) (13). Serial culture passaging
of hCPCe lines led to decreased NS expression (23%)
(Figure 5D) that coincides with acquisition of repli-
cative senescence in vitro. Conversely, Pim-1 over-
expression signiﬁcantly increased NS expression in
all AhCPC lines (60%) (Figure 5D, Online Figures 6A
and 6B). Collectively, these results are consistent
with Pim-1 modiﬁcation of AhCPCs extending culture
time and serial passaging before achieving replicative
senescence (13).
Effects on c-Myc are important given that c-Myc is
necessary and sufﬁcient for NS regulation, shown
by modiﬁcation of YCPCs to overexpress c-Myc
(increased 3.1-fold) that elevates NS expression (2.5-
fold); conversely, knockdown or pharmacologic inhi-
bition of c-Myc signiﬁcantly decreases NS expression
(61%, 49%) (Figures 6A and 6B). c-Myc participa-
tion in NS induction by Pim-1 was conﬁrmed
in AhCPCs, where c-Myc silencing signiﬁcantly
decreased NS expression in hCPCe (41%) and
hCPCeP lines (54%) (Figure 6C), consistent with a
role for c-Myc as a crucial intermediate for Pim-
1–mediated activation of NS. c-Myc–dependent regu-
lation of NS gene expression was conﬁrmed using
CPCs expressing GFP under control of the NS pro-
moter isolated from transgenic mouse hearts (21),
with GFP-reporter expression and ﬂuorescence
decreased 65% after silencing of c-Myc, as well as a
73% decrease in NS mRNA (Figures 6D to 6F).
REJUVENATION OF SENESCENT CPCS. The senes-
cent phenotype can be mitigated by NS overex-
pression in OCPCs and AhCPCs subjected to serial
passaging in vitro (Figure 7A). Alteration in mor-
phology and reduction in the percentage of
senescent and multinucleated cells, consistent with
restoration of “youthful” phenotype, are evident
in senescent cells overexpressing NS (Figures 7B
to 7F). NS overexpression evidently is an effective
strategy to potentiate rejuvenation of OCPC and
AhCPCs.
STEM CELL EXHAUSTION AND CARDIAC AGING. The
Central Illustration and Figure 8 demonstrate that NS
is required to maintain myocardial youth and prevent
CPC exhaustion. That NS extends inﬂuences beyond
cultured CPCs and impacts on myocardial aging is
evident in NSþ/- mice hearts demonstrating a dra-
matic decline in ejection fraction (44%) associated
with increases in left ventricular inner diameter andvolume at systole by 3 months of age, consistent with
a heart failure phenotype (Figures 8A to 8C, Online
Table 1). p53 expression increased in NSþ/- mice
hearts at 1 month (2.4-fold) remains elevated with age
(2.1-fold at 3 months) (Figure 8D, Online Figure 7).
Coincident with loss of function, p16 expression is
elevated at 3 months (1.8-fold) but not at 1 month,
indicating predisposition to early cardiac senescence
and associated functional decline (Figure 8D, Online
Figure 7). Furthermore, loss of NS also causes telo-
mere attrition (30%) (Figure 8E) accompanied by
accumulation of senescent g-H2AXþ CPCs within 1
month after birth (Figures 8F and 8G), suggesting that
CPC exhaustion is likely to contribute to the early
cardiac aging phenotype evident in NSþ/- mice, thus
providing a compelling role for NS in maintaining
myocardial youth and preserving CPC stemness and
function.
DISCUSSION
Organ aging and senescence at the cellular level
occur differentially with select cells possessing
advanced senescence characteristics and impaired
function relative to others (1). Senescent stem cells
affect their microenvironment by decreasing regen-
erative potential of the entire stem cell pool, while
also affecting neighboring myocytes and vasculature.
Therefore, identifying molecular characteristics
of cellular senescence and speciﬁcally selecting for
a “youthful” population of stem cells bereft of
senescent cells would ideally enhance stem cell–
mediated regeneration, accompanied by genetic en-
gineering strategies to promote retention of youthful
characteristics.
Results of our study delineate a novel, evolution-
arily conserved role for NS to affect the senescence of
c-kitþ CPCs isolated from mice and fetal and adult
human hearts. Molecular characteristics of senes-
cence concomitantly associated with morphological
changes, including cellular “ﬂattening” (13) and
acquisition of 2 or more nuclei, are found in OCPCs
and AhCPCs (Figure 2) and seen in many proliferating
cell types, including other mammalian cell systems,
suggesting that polyploidy and/or binucleation in-
duces cell cycle arrest eventually leading to senes-
cence or quiescence (9,22). Nonsenescent binucleate
CPCs account for a minimal basal percentage of
the population in YCPCs (2% to 3%); however, pro-
senescent stimuli such as increased age or NS
knockdown prompt concurrent acquisition of binu-
cleation and senescence with 96% of binucleate CPCs
expressing SA-b-galþ. Polynucleation observed only
in mouse CPCs correlates 100% with senescence; all
FIGURE 6 c-Myc in NS Regulation
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142polynucleate cells are senescent, and induction of
polynucleation occurs only under a pro-senescent
stress stimulus (Online Figures 2 and 3). To
our knowledge, this is the ﬁrst study in CPCs
demonstrating multinucleation, a generally accepted
indicator of senescence in noncardiac cells. Collec-
tively, our data indicate that multinucleation andacquisition of cell-autonomous senescence occur
concomitantly such that mononucleated CPCs are
likely to possess enhanced proliferative and regen-
erative potential. The multinucleated progenitors’
role may be to confer cell cycle arrest and senescence
on neighboring mononucleate cells through a
bystander effect via a paracrine signaling mechanism
FIGURE 7 Rejuvenated Senescent CPCs
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143(1). Of note, both multinucleation and senescence
are causally linked to loss of NS, which declines in
morphologically altered senescent OCPCs and
AhCPCs (Figure 2, Online Figure 2).
The pivotal role of NS in regulating proliferation
(3,4) is evident in NS homozygous knockout mice
that experience embryonic lethality and abort spon-
taneously at the early blastocyst stage because
of impaired proliferation (3,5,7). NS regulates cell
cycle at both G1/S and G2/M phases in a cell-type–dependent manner (5,7,10,11,23), with cell cycle
analyses in YCPCs upon NS knockdown showing
decreased S phase measured by both BrdU incorpo-
ration assays and ﬂuorescent imaging (Figure 3). NS
silencing increases cell cycle arrest markers p53 and
p16 in YCPCs and AhCPCs, portraying a collective
scenario wherein NS loss prompts increased senes-
cence with cell cycle arrest in the G1/S phase.
Dependence on p53 for loss of NS-mediated cell cycle
arrest remains controversial (4,10,11), but our ﬁndings
CENTRAL ILLUSTRATION Schematic of Hypothetical Signaling Cascade
Stem Cell Exhaustion
• Cell cycle arrest
• Loss of morphology
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Hariharan, N. et al. J Am Coll Cardiol. 2015; 65(2):133–47.
Pim-1 stabilizes c-Myc that in turn transcriptionally activates nucleostemin (NS). Loss of NS up-regulates p53 and regulates cellular senes-
cence, characterized by cell cycle arrest, loss of morphology, increased senescence-associated beta-galactosidase (SA-b-gal) activity,
increased multinucleation, and decreased expression of stemness markers. Loss of NS also leads to accumulation of exhausted cardiac
progenitor cells (CPCs) in vivo causing cardiac aging. Inhibition mediated by knockout mice and lentivirus-based gene knockdown is indicated
in boxes below. KO ¼ knockout.
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144show that senescence mediated by NS silencing in
YCPCs and AhCPCs is at least partly p53-dependent
(Figure 4). Depletion of p53 before NS knockdown
partly attenuates short hairpin-NS–induced senes-
cence associated with cell cycle arrest and loss of
morphology. Future studies will be needed to deter-
mine whether cardiac-speciﬁc p53 inhibition can
rescue the senescent phenotype observed within
weeks after birth in NSþ/- mice (Figure 8). NS-
mediated regulation of cytokinesis occurs indepen-
dently of p53, consistent with selective inhibition of
Aurora B kinase causing multinucleation in tumor
cells independently of p53 (24). Although the exact
mechanism for NS-mediated regulation of cytokinesis
is unknown, Aurora B kinase (a critical regulator of
cytokinesis) (20) seems to be inﬂuenced by NS
silencing (Figure 3). Just as we require NS to maintain
CPC function and prevent stem cell exhaustion, our
data demonstrate that NS overexpression holds the
potential to rejuvenate old mouse and human CPCs
(Figure 7), corroborating previous ﬁndings demon-
strating that transgenic NS overexpression decreases
senescent mouse embryonic ﬁbroblasts isolated from
NSþ/- mice (5).Maintaining telomere length is an important facet
of NS-mediated senescence regulation; a strong pos-
itive correlation between NS expression and telomere
length is evident in human CPCs and hearts (Figure 1).
NSþ/- mice consistently show dramatic reduction in
cardiac telomere length within 10 days after birth
(Figure 8). NS prevents telomeric shortening by well-
studied mechanisms involving degradation of telo-
meric repeat binding factor-1, a negative regulator of
telomere length, and by promoting recruitment and
interaction of deoxyribonucleic acid repair protein
complexes to telomeric ends (5,25,26). NS localization
and interaction with telomeric proteins to maintain
telomere length also may play an important role in
cytokinesis, considering that dysfunctional telomeres
cause cytokinesis failure leading to accumulation of
binucleate cells (27). NS overexpression increases
telomerase reverse transcriptase expression and
increases telomere length in CPCs (8). Consistent with
preservation of telomere integrity, Pim-1 over-
expression maintains telomeres in CPCs (16), but
the connection to NS in mediating Pim-1–driven
preservation of telomeric integrity remains a topic for
future investigation.
FIGURE 8 NS and Cardiac Aging
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NS haploinsufﬁciency causes cardiac aging preceded by stem cell exhaustion. (A–C) Echocardiographic measurements of ejection fraction (EF%)
(A), left ventricular inner diameter systolic (LVID [s]) (B), and left ventricular volume systolic (LV vol [s]) (C) in male NSþ/- and NTg mice at
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analyses of p53 and p16 levels in NSþ/- and NTg mice hearts at 3 months of age (N ¼ 3 each). (E) Telomere length (Kbp) measured by q-PCR
in NSþ/- and NTg mice at 10 days after birth (N ¼ 6 NTg; 5 NSþ/-). (F, G) Counts of senescent CPCs at 1 month of age identiﬁed as c-kitþ,
g-H2AXþ CPCs (arrow indicates a senescent c-kitþ, g-H2Axþ CPC) (F) determined by staining parafﬁn heart sections with c-kit (green), g-H2AX
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145Stem cell commitment is tied to NS as inferred
from down-regulation of NS upon differentiation
and, conversely, acquisition of lineage commitment
phenotype after NS knockdown (5,7,8). However, in
an in vitro environment devoid of appropriate
commitment cues, NS silencing in CPCs leads to
phenotypic changes predominantly consistent withsenescence without promotion of differentiation
(Figure 3). As a quintessential marker of “stemness”
and pluripotency in embryonic stem cells (7), NS
is similarly associated with maintenance of CPC
morphology and expression of markers associated
with stemness, while being required to prevent CPC
exhaustion in vivo (Central Illustration). NS expression
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: NS is
associated with maintenance of CPCs. Decline in NS is
associated with and causal to senescence of CPCs and
early myocardial aging accompanied by transition to
heart failure.
TRANSLATIONAL OUTLOOK: NS can be used as a
molecular marker to identify stem cells with enhanced
regenerative potential and distinguish senescent CPCs
isolated from patients. Targeting NS could be a
promising strategy to antagonize cardiac senescence
and maintain myocardial youth.
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146identiﬁes CPCs with enhanced regenerative potential
decreased senescence characteristics and increased
stemness, thus differentiating NS from markers such
as p16 and telomere length used in published clinical
trials with CPCs to determine senescence.
In the myocardium, NS expression decreases with
age as seen in mouse (8) and human hearts, and
deletion of 1 allele of NS in a murine system can cause
early cardiac aging, associated with exhaustion of
CPCs, telomere attrition, up-regulation of molecular
markers of senescence, and decline in cardiac func-
tion resembling a heart failure phenotype. Under-
standing NS regulation and mechanism of action is
essential to improve strategies to preserve the
regenerative potential of aging stem cells, particu-
larly with regard to upstream mediators of NS
expression and stabilization, such as Pim-1 and c-Myc
(Central Illustration). Antagonism of senescence by NS
may contribute to enhanced myocardial regeneration
mediated by Pim-1, providing a novel mechanistic
molecular direction for future studies.
STUDY LIMITATIONS. Adult human CPCs isolated
from explants of patients with end stage heart failure
receiving an LVAD implant have been compared to
fetal CPCs for senescence characteristics and NS
expression. A limitation of the study is the determi-
nation of correlation between studies in mice versus
human tissues, and future investigations will need to
expand these analyses to establish the parallels be-
tween experimental animal models such as the mice
used herein and human biology.
CONCLUSIONS
Molecular characteristics of senescence acquired
by CPCs as shown in the current study, includingdown-regulation of NS expression, serve as markers to
identify and distinguish senescent AhCPCs isolated
from patients. Thus, using NS expression as a prog-
nostic indicator of regenerative potential will provide
a rational basis for identifying those individuals
who would beneﬁt most from genetic engineering
of their CPCs with Pim-1 to enhance youthful pheno-
typic traits, antagonize aging, and augment regenera-
tion (13).
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